European Lithium Limited (EURO) 시세

You think right

Misleading....gibberish....gibberish....gibberish .....kick the can.....gibberish....gibberish.......it will never happen.....gibberish....gibberish. It's actually comical at this point how someone can be wrong on literally EVERY prediction. 

He needs to change his name from Kund to M

NoGro continues to provide a one-sided opinion which is the real con job. IMO
Who cares about PFS with respect to DCVax-L when the statistical guess is overturned by the true OS data, "the golden standard".

Sounds like Brookmount/Nils really has you guessing.

Do you like Gabanzo beans Or pinto beans? Mexican or Guatemalan, like to pick Watermelons as a profession.

Or it will trade flat.


(more low hanging fruit)

HMBL it's a share selling scheme.

Sry

https://www.facebook.com/share/r/1BL3hkN6FC/?mibextid=wwXIfr

Gary, I can't think of any time where the major regulators have jointly evaluated a drug or vaccine. I may be wrong, but each regulator has their own processes and if such a cooperative effort had occurred it would be well known.
As far as EDEN approval, I'd just be happy to hear a finished u

Are IPIX shareholders destined to lose our control over Brilicidin the same way we got it; through a bargain basement bankruptcy auction?
gh

Geez let the stock run 
Enjoy that beer money 

imo

He's [Mayo] surmising because of his view that the drug is valuable.

Do you have a contrary opinion that the drug is not valuable? I know you didn't say that but I am surprised at your captioning Mayo's thoughts as a guess, especially in light of recent positive developments. I supp

Of course conversions affect price share. Also, keep in mind as long as conversions continue boiler plate language in those loans usually don’t allow company to buy back shares. However, overall share structure, income, and ongoing business growth and types of business focus are better than most OTC

I bought 70 mil more while you were gone. They all run eventually. You’re even wishing that for your POS beer stock. No difference. I had 100 mil shares of a no bid scam years ago that ran to .01+ without a reverse and still trades .002+. Never discount a “scam” as you call it with potential. Pop th

CBB.....anytime you own a stock that increases 16% in value in a day.....get excited.

Doubt it. You wall flower. They call you “Chester” when you arrive. They trans strip club. Not my like but to each own have fun bit boy

LOL  Shorting OTC  😂   Only the big boys do that!  The rules are too difficult!  

Jim Rice finally got over the HOF line in his 15th and final year on the ballot, which is hard to believe for a guy with his career numbers. This is a case of baseball writers playing games by witholding their vote and exercising payback-spite for a guy who openly held them in low esteem. IMO this o

Picking up another $400 worth tomorrow, plan on buying up till uplist!!!!

Someone posted on the wallstreetbet Facebook page they’re exploring the quantum computing security sector. If true, we go to the moon. $SAKL

Information from ai Grock2

https://x.com/i/grok/share/4fWEFcJG7TEaWzIZMCUitF8Lv

BIEL: AMAZON/APPLE TYPE INVESTMENT!!

When BIEL hits .01, the return on investment for a .0003 buy will be greater than the 10 year ROI (over 3,000%) for Amazon and Apple.

BIEL can hit copper in IN THE BLINK OF AN EYE, as $1.5 -2 million annual revenue (or a $400k quarte

Who has more inaccurate predictions than Kund?

Kund: (1) the MAA will never be submitted, Missling will "kick the can" (wrong); (2) the MAA will not be accepted (wrong); (3) the peer review will never be published (wrong). 

So what is this genius's latest prediction? Wh

zero82,

“I don't see that coming in 2025” …

If you saw it coming then it wouldn’t be “Stealth Mode”
https://investorshub.advfn.com/uimage/uploads/2024/10/5/jgowtgiphy.gif
https://nwbio.com/audio-of-nwbio-2023-annual-shareholders-meeting/

h

TTX-CRISPR: a Gene transference Drug, Initially developed by TransCode Therapeutics, Inc., Now, its global highest R&D status is Discovery, Mechanism:
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a leading clinical-stage oncology company committed to using its proprietary platform delivery s